4SC Public
Our products shall provide patients with innovative treatment options being more tolerable and efficacious than existing ones for a better quality of life.
Industry:
PharmTech
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Investors Number:
9
Headquarters:
Germany
Employee Number:
51-100
Total Funding:
94700000 EUR
Founded Date:
1997
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2019-11-12